Issue 003 | U.S. Pilot | US

MHUAF

Meihua International Medical Technologies Co., Ltd.

Screen state: Passing Source state: Verified 20-F | 2026-04-29 Filing currency: USD
Internal NCAV Discount 95.5%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
153,583,568USD
Total Liabilities
18,251,143USD
NCAV
135,332,425USD
Cash
15,153,909USD
NCAV per share
3.78USD/share
Evidence
5 annual | 7 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Evaluated
12
Triggered
4
Unavailable
3
Supporting observation NCAV Growing 135,332,425
Latest
135,332,4252025-12-31
Comparison
116,174,7532024-12-31
Change
+16.5%

Basis: equivalent prior-year NCAV change >= +2%; both NCAV values must be positive

Source periods: SEC 20-F 2025-12-31 · 0001213900-26-049081; REPORTED_FILING 20-F 2024-12-31

Supporting observation Positive OCF 569,883
Latest
569,8832025-12-31
Comparison
n/a
Change
n/a

Basis: latest reporting-period cash from operations > 0

Source periods: SEC 20-F 2025-12-31 · 0001213900-26-049081

Supporting observation Share Count Reduced 697,914
Latest
697,9142025-12-31
Comparison
31,904,4682024-12-31
Change
-97.8%

Basis: 1Y share change <= -2% using the same share-count source

Source periods: SEC 20-F 2025-12-31 · 0001213900-26-049081; REPORTED_FILING 20-F 2024-12-31

Supporting observation Current Ratio > 1.5 8.42
Latest
8.422025-12-31
Comparison
1.5
Change
n/a

Basis: current assets / current liabilities; strong if > 1.5

Source periods: SEC 20-F 2025-12-31 · 0001213900-26-049081

3 unavailable checks — inspect missing inputs
High Debt (short-term debt + long-term debt) / ordinary equity >= 50%
Low Debt (short-term debt + long-term debt) / ordinary equity < 20%
Non-Positive Equity ordinary shareholders equity <= 0

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Data Vault has not published the normalized share-count artifact for this company.

Known Unknowns

Only 7 quarterly periods available from Data Vault for this company.

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
20-F
USD
2024-12-31
20-F
USD
2023-12-31
20-F
USD
2022-12-31
20-F
USD
2021-12-31
20-F
USD
Revenue 61,791,957 96,909,642 97,098,915 29,196 575,901
Operating Income 8,283,912 14,311,915 14,674,938 10,801,962 26,260,954
Net Income 6,781,826 10,843,589 11,625,417 6,242,969 20,949,579
Cash From Operations 569,883 14,636,805 2,275,750 -9,163,038 -54,663
Capex -15,629 -133,550 -1,182,699 -2,698,729 -850,231
Free Cash Flow 554,254 14,503,255 1,093,051 -11,861,767 -904,894
Cash And Equivalents n/a n/a 16,926,878 26,736,700 8,149,276
Accounts Receivable 84,325,038 78,660,700 78,570,956 68,945,792 67,101,297
Inventory 1,704,309 1,409,639 1,617,225 1,122,038 1,251,393
Total Current Assets 153,583,568 143,438,322 132,237,053 135,319,155 97,276,350
Total Assets 207,182,355 186,239,116 171,915,272 163,577,579 136,857,381
Total Current Liabilities 18,251,143 27,263,569 25,072,858 24,173,567 29,088,779
Total Liabilities 18,251,143 27,263,569 25,077,450 24,898,499 29,088,779
Shareholders Equity 188,931,212 158,975,547 146,331,840 138,122,937 107,768,602
Shares Outstanding 697,914 31,904,468 23,940,000 23,940,000 23,940,000
Shares Outstanding Diluted n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 376,035 27,371,707 23,940,000 23,411,068 20,000,000
Weighted Avg Shares Basic 376,035 27,371,707 23,940,000 23,411,068 20,000,000
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Only 7 quarterly periods available from Data Vault for this company.

Metric
2025-06-30
6-K
USD
2024-12-31
6-K
USD
2024-06-30
6-K
USD
2023-12-31
6-K
USD
2023-06-30
6-K
USD
2022-12-31
6-K
USD
2022-06-30
6-K
USD
Revenue 37,981,619 96,909,642 45,343,698 97,098,915 48,190,076 103,346,341 29,666
Operating Income 3,239,105 14,311,915 5,892,012 14,674,938 9,096,673 10,801,962 8,668,702
Net Income 3,145,022 10,843,589 4,716,590 11,625,417 7,062,007 6,242,969 6,554,887
Cash From Operations -9,902,327 14,636,805 1,015,799 2,275,750 -5,424,569 -9,163,038 -7,798,816
Capex -10,242 -133,550 -10,422 -1,182,699 -1,001,925 -2,698,729 -459,163
Free Cash Flow -9,912,569 14,503,255 1,005,377 1,093,051 -6,426,494 -11,861,767 -8,257,979
Cash And Equivalents n/a n/a n/a 16,926,878 17,861,214 26,736,700 n/a
Total Current Assets 146,340,878 143,438,322 141,313,649 132,237,053 132,264,679 135,319,155 n/a
Total Liabilities 25,639,049 27,263,569 29,590,466 25,077,450 23,221,700 24,898,499 n/a
Shares Outstanding 31,904,468 31,904,468 26,093,796 23,940,000 23,940,000 23,940,000 n/a
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 31,904,468 27,371,707 30,716,582 23,940,000 23,940,000 23,411,068 22,873,370
Weighted Avg Shares Basic 31,904,468 27,371,707 25,056,143 23,940,000 23,940,000 23,411,068 22,873,370
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 146,340,878USD us-gaap:AssetsCurrent 2025-06-30 1.00 Data Vault | sec/companyfacts/cik=0001835615/companyfacts.json
Data Vault | sec/companyfacts/cik=0001835615/companyfacts.json
Total Liabilities 25,639,049USD us-gaap:Liabilities 2025-06-30 1.00 Data Vault | sec/companyfacts/cik=0001835615/companyfacts.json
Data Vault | sec/companyfacts/cik=0001835615/companyfacts.json
Cash n/a derived 2025-06-30 n/a n/a
Shares Outstanding 31,904,468 us-gaap:CommonStockSharesOutstanding 2025-06-30 1.00 Data Vault | sec/companyfacts/cik=0001835615/companyfacts.json
Data Vault | sec/companyfacts/cik=0001835615/companyfacts.json
NCAV 120,701,829USD derived 2025-06-30 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 3.78USD derived 2025-06-30 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 95.5% derived 2025-06-30 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
n/a
CIK
0001835615
Company ID
n/a
Selected Annual Source
n/a
Selected Quarterly Source
n/a
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
8
Imported At
2026-08-15T12:52:28+00:00
Rendered At
2026-08-16T03:29:48+00:00

Run Audit

Mary Run
8f67c1da7de642feb640d04491409c50
Mary As Of
2026-07-25
Accession
0001213900-26-049081
CIK
0001835615
Mary Filing Date
2026-04-29
Filing Currency
USD
Internal Discount
95.5%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=8f67c1da7de642feb640d04491409c50; mary_as_of=2026-07-25; mary_filing_date=2026-04-29; mary_accession=0001213900-26-049081; mary_cik=0001835615; gnni_supporting_filing_date=2026-04-29; internal_discount=0.954773; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive